Banner for leaf pages 2

Raloxifene (Evista)

Also known as Evista

Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.

Source: Wikipedia

Estimated Total Cost: $104.79 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed raloxifene to treat bone disorder, osteoporosis, menopause, and atrophic vaginitis.

Ajax-loader Loading...